ABCC3 as a marker for multidrug resistance in non-small cell lung cancer

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Zhao, Yanbin ^a   Lu, Hailing ^a   Yan, An ^a   Yang, Yanmei ^a   Meng, Qingwei ^a   Sun, Lichun ^a   Pang, Hui ^a   Li, Chunhong ^a   Dong, Xiaoqun ^b   Cai, Li ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 3;

CLUSTER ANALYSIS; DRUG RESISTANCE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; MORTALITY; MULTIDRUG RESISTANCE; NON SMALL CELL LUNG CANCER; PROGNOSIS;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CLUSTER ANALYSIS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROGNOSIS;

EID: 84887373496     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03120     Document Type: Article

References (28)

1. Jemal, A., Siegel, R., Xu, J. , E. Cancer statistics, 2010. CA Cancer J clin 60, 277-300, 20073 (2010).
2. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 375, 1267-1277 (2010).
3. Bertelsen, C. A., Sondak, V. K., Mann, B. D., Korn, E. L. &Kern, D. H. Chemosensitivity testing of human solid tumors. Areview of 1582 assayswith 258 clinical correlations. Cancer 53, 1240-1245 (1984).
4. Shaw, G. L. et al. Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer. J Cell Biochem Suppl. 24, 173-185 (1996).
5. Kobayashi, H. Collagen gel droplet culture method to examine in vitro chemosensitivity. Methods Mol Med. 110, 59-67 (2005).
6. Yoshimasu, T. et al. Data acquisition for the histoculture drug response assay in lung cancer. The J Thorac Cardiovasc Surg. 133, 303-308 (2007). (Pubitemid 46136244)
7. Higashiyama, M. et al. Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients. Lung cancer 68, 472-477 (2010).
8. Deeley, R. G.,Westlake, C. &Cole, S. P. Transmembrane transport of endo-and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins. Physiological Rev 86, 849-899 (2006). (Pubitemid 44033384)
9. Kruh, G. D., Belinsky, M. G., Gallo, J. M. &Lee, K. Physiological and pharmacological functions of Mrp2, Mrp3 and Mrp4 as determined from recent studies on gene-disrupted mice. Cancer metastasis Rev 26, 5-14 (2007). (Pubitemid 46452179)
10. Marquez, B. &Van Bambeke, F. ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions. Curr Drug Targets 12, 600-620 (2011).
11. Borst, P., Zelcer, N. &van de Wetering, K. MRP2 and 3 in health and disease. Cancer Lett 234, 51-61 (2006). (Pubitemid 43343940)
12. Young, L. C. et al. Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response. Clin Cancer Res. 5, 673-680 (1999). (Pubitemid 29131979)
13. Young, L. C., Campling, B. G., Cole, S. P., Deeley, R. G. &Gerlach, J. H. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. Clin Cancer Res. 7, 1798-1804 (2001). (Pubitemid 32708651)
14. Kool, M. et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A 96, 6914-6919 (1999). (Pubitemid 29274984)
15. Lockhart, A. C., Tirona, R. G. &Kim, R. B. Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy. Mol Cancer Ther. 2, 685-698 (2003).
16. Hong, X. et al. Multidrug resistance-associated protein 3 and Bcl-2 contribute to multidrug resistance by vinorelbine in lung adenocarcinoma. Int J Mol Med. 28, 953-960 (2011).
17. Konig, J. et al. Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. Int J Cancer. 115, 359-367 (2005). (Pubitemid 40663738)
18. Kuan, C. T. et al. MRP3: a molecular target for human glioblastoma multiforme immunotherapy. BMC cancer 10, 468 (2010).
19. O'Brien, C. et al. Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer. Cancer Res. 68, 5380-5389 (2008).
20. Hanada, S. et al. Expression profile of early lung adenocarcinoma: identification of MRP3 as a molecular marker for early progression. J Pathol. 216, 75-82 (2008).
21. Daraselia, N. et al. Molecular signature and pathway analysis of human primary squamous and adenocarcinoma lung cancers. Am J Cancer Res. 2, 93-103 (2012).
22. Petty, R. D., Nicolson, M. C., Kerr, K. M., Collie-Duguid, E. , G. I. Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clin Cancer Res. 10, 3237-3248 (2004). (Pubitemid 38685427)
23. Liu, Y., Peng, H., J. T. Expression profiling of ABC transporters in a drugresistant breast cancer cell line using AmpArray. Mol Pharmacol. 68, 430-438 (2005). (Pubitemid 41058306)
24. Hagmann, W., Jesnowski, R., Faissner, R., Guo, C. &Lohr, J. M. ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells. Pancreatology. 9, 136-144 (2009).
25. Wang, X. B. et al. Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells. Oncol Rep. 23, 211-215 (2010).
26. Keiko Yagi, K. K., Kunio li &Seiki Tashiro. Relationship of P-Glycoprotein and p53 Protein to Chemosensitivity in Colorectal Cancer. Int J Clin Oncol. 2, 81-91 (1997). (Pubitemid 127730546)
27. Chen, Z., Liu, G., Chen,M., Xu, B., Peng, Y., Chen, M., M. Screen anticancer drug in vitro using resonance light scattering technique. Talanta. 77, 1365-1369 (2009).
28. Kuang, Y. H., Chen, X., Su, J., Wu, L. S., Liao, L. Q., Li, D., Chen, Z. S. &Kanekura, T. RNA interference targeting the CD147 induces apoptosis of multi drug resistantcancer cells related to XIAP depletion. Cancer Lett. 276, 189-95 (2009).